ReviewIBRO neuroscience reports2026
Incidence of cranial and ophthalmic nerve palsy and associated risk factors in tuberculous meningitis: A systematic review and meta-regression analysis.
Review in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculous meningitis (TBM) is the most severe form of extrapulmonary tuberculosis, frequently complicated by cranial nerve palsy (CNP) and ophthalmic nerve palsy (ONP), which are associated with poor prognosis. Understanding their incidence and associated risk factors is essential for timely diagnosis and improved management. Method: This study conducts a systematic review and meta-analysis of research on CNP and ONP in TBM patients. Several medical databases were searched from the earliest records to April 2025. Eligible studies included cohort studies, cross-sectional studies, case-control studies, and baseline data from clinical trials. Two independent reviewers extracted data and assessed quality. Pooled incidence rates were estimated using random-effects models. Univariable meta-regression explored potential risk factors. Result: Forty-seven diverse studies published between 1977 and 2025 from around the world with varying samples sizes were included. The pooled prevalence of CNP in TBM patients was 26.5 % (95 % CI: 22.4-31.1 %), while ONP prevalence was 23.9 % (95 % CI: 18.7-30.0 %). Between-study heterogeneity was substantial. In univariable meta-regression, hydrocephalus was associated with higher incidence of both outcomes, whereas cerebral infarction and higher CSF protein were additionally associated with CNP. These findings represent study-level associations and should be interpreted cautiously. Conclusion: Around one-quarter of TBM patients experience cranial nerve palsy and approximately one-quarter develop ophthalmic nerve palsy. Hydrocephalus emerged as the most consistent correlate of both outcomes. Cerebral infarction and higher CSF protein were also associated with higher CNP incidence. Early identification and management of these complications may improve neurological outcomes, but variability across settings should be interpreted cautiously. Registration number: PROSPERO CRD42025649903.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.